Loading clinical trials...
Loading clinical trials...
The OCS™ Heart System will be used to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria for transplantation in this continued access protocol.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
TransMedics
NCT06325280 · Pediatric ALL, Congenital Heart Disease, and more
NCT05732779 · Heart Transplant Rejection, Immune Suppression, and more
NCT07359690 · Heart Transplantation, Dilated Cardiomyopathy (DCM), and more
NCT07291258 · Solid Organ Transplantation, Pregnancy, and more
NCT05025774 · Chronic Lung Disease, Chronic Obstructive Pulmonary Disease, and more
Cedars-Sinai
Los Angeles, California
Stanford University
Palo Alto, California
Yale New Haven Hospital
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions